TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive NIH Director: NCI’s Special Authorities “More Of A Negative Than A Positive” June 11, 2010
TCL Archive NIH Grant Funding to Use Percentiles Instead Of Priority Scores; Minimal Impact Seen By NCI January 22, 1988
TCL Archive In Brief: Senate Markup Of Cancer Act Renewal Bill Delayed Again; New Money Levels Considered Still Too Low November 9, 1979
